|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1401 K Street NW Suite 1200 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 35800-48
|
||||||||
|
6. House ID# 307700021
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Alicia W. Smith, Sr. VP & Corp. Secretary |
Date | 10/18/2017 11:51:59 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1156 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text)
S 1133 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text)
Discussions involving potential reform of health care delivery and payment systems implemented by The Affordable Care Act
HR 277 American Health Care Reform Act of 2017 (all sections of full text)
Discussions involving US Senate Graham-Cassidy health care legislation
Discussions pertaining to HR 1628 American Health Care Act of 2017 (all sections of full text)
Monitored S 297 Increasing Competition in Pharmaceuticals Act
Monitored HR 749 Lower Drug Costs through Competition Act
Monitored S 1115 Making Pharmaceutical Markets More Competitive Act
Monitored HR 208 Ensuring Health Care Opportunities Act
Monitored discussions that would result in additional federal regulation of Group Purchasing Organizations
Monitored S 1115 Making Pharmaceutical Markets More Competitive Act
Monitored HR 2562 Making Pharmaceutical Markets More Competitive Act
Monitored S 191 Patient Freedom Act of 2017
Monitored S 761 Health Care Options Act of 2017
Monitored HR 1933 Health Care Options Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
W. Timothy |
Locke |
|
|
|
Summer |
Mersinger |
|
|
|
Robert |
Hickmott |
|
|
|
Jack S. |
Deuser |
|
|
|
Trevor |
Kolego |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Discussions pertaining to CMS IPPS Rule and Medicare DSH/S10 conversion
Budget sequestration limits on Medicare spending
Monitored HR 1130 Fair Medicare Hospital Payments Act of 2017
Monitored S 41 Medicare Prescription Drug Price Negotiation Act of 2017
Monitored HR 242 Medicare Prescription Drug Price Negotiation Act of 2017
Monitored S 260 Protecting Seniors' Access to Medicare Act of 2017
Monitored S 251 Protecting Medicare from Executive Action Act of 2017
Monitored HR 849 Protecting Seniors' Access to Medicare Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
Jack S. |
Deuser |
|
|
|
W. Timothy |
Locke |
|
|
|
Summer |
Mersinger |
|
|
|
Robert |
Hickmott |
|
|
|
Trevor |
Kolego |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Monitored proposed changes and stabilization of the health insurance market
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
W. Timothy |
Locke |
|
|
|
Jack S. |
Deuser |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Discussions related to federal natural disaster assistance for hospitals and The Stafford Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
W. Timothy |
Locke |
|
|
|
Trevor |
Kolego |
|
|
|
Robert |
Hickmott |
|
|
|
Jack S. |
Deuser |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Discussions involving data and monitoring of clinical productivity and efficiency in the Department of Veterans Affairs
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
W. Timothy |
Locke |
|
|
|
Robert |
Hickmott |
|
|
|
Trevor |
Kolego |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |